HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antithrombin Cambridge II mutation as a risk factor to develop cerebral venous thrombosis.

AuthorsPere Barba, Amparo Santamaría, Isabel Tirado, Edelmira Martí, Jordi Fontcuberta
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 99 Issue 2 Pg. 443-4 (Feb 2008) ISSN: 0340-6245 [Print] Germany
PMID18278198 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • antithrombin Cambridge II
  • Antithrombin III
Topics
  • Adult
  • Antithrombin III (genetics)
  • Genetic Predisposition to Disease
  • Heterozygote
  • Humans
  • Inflammatory Bowel Diseases (complications)
  • Intracranial Thrombosis (etiology, genetics)
  • Male
  • Mutation
  • Pedigree
  • Risk Factors
  • Thrombophilia (complications, genetics)
  • Venous Thrombosis (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: